Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

A quality indicator set for systemic lupus erythematosus.

Jinoos Yazdany1, Pantelis Panopalis, Joann Zell Gillis

  • 1Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco, CA 94143-0920, USA. jinoos.yazdany@ucsf.edu

Arthritis and Rheumatism
|February 28, 2009
PubMed
Summary

A new set of 20 quality indicators (QIs) for systemic lupus erythematosus (SLE) was developed. This rigorous process ensures valid and feasible indicators to assess and improve SLE patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming Rheumatology Practice: Applications of Generative Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same author

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

Voclosporin and Changes in Blood Pressure: An Analysis of Real-World Data.

Arthritis care & research·2026
Same author

Neighborhood Socioeconomic Status and Short-Term Functional Outcomes in Systemic Lupus Erythematosus.

Arthritis care & research·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026

Area of Science:

  • Rheumatology
  • Health Services Research
  • Quality Improvement

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease requiring comprehensive management.
  • Assessing and improving the quality of care for SLE patients is crucial for better health outcomes.
  • Existing quality indicators for SLE may be limited or outdated.

Purpose of the Study:

  • To systematically develop a comprehensive set of quality indicators (QIs) for systemic lupus erythematosus (SLE).
  • To establish valid and feasible indicators for evaluating healthcare quality in SLE patients.

Main Methods:

  • A validated process combining scientific evidence and expert consensus was employed.
  • Systematic literature review of clinical practice guidelines identified 20 candidate indicators.

Related Experiment Videos

Last Updated: Jun 25, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

  • Two rounds of expert panel voting and a modified RAND/UCLA Appropriateness Method refined the indicators.

    • Main Results:

    • A final set of 20 quality indicators (QIs) were rated as valid and feasible by an expert panel.
    • The QIs cover critical areas including diagnosis, preventive strategies, osteoporosis management, toxicity monitoring, renal disease, and reproductive health.
    • These indicators provide a framework for assessing the quality of care delivered to SLE patients.

    Conclusions:

    • A rigorous, multistep approach involving literature reviews and expert consensus successfully developed QIs for SLE.
    • This new QI set offers a valuable tool for assessing healthcare quality in SLE.
    • These indicators represent a significant step towards improving the management and outcomes for patients with SLE.